Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVJF) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Teva Pharmaceutical Industries (TEVJF) over the last 17 years, with Q4 2025 value amounting to -$13.8 billion.

  • Teva Pharmaceutical Industries' Retained Earnings rose 929.94% to -$13.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$13.8 billion, marking a year-over-year increase of 929.94%. This contributed to the annual value of -$13.8 billion for FY2025, which is 929.94% up from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Retained Earnings stood at -$13.8 billion for Q4 2025, which was up 929.94% from -$14.2 billion recorded in Q3 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Retained Earnings peaked at -$2.4 billion during Q2 2021, and registered a low of -$15.2 billion during Q4 2024.
  • Its 5-year average for Retained Earnings is -$10.0 billion, with a median of -$13.6 billion in 2023.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Retained Earnings skyrocketed by 7638.79% in 2021, and later plummeted by 40621.99% in 2024.
  • Over the past 5 years, Teva Pharmaceutical Industries' Retained Earnings (Quarter) stood at -$2.7 billion in 2021, then decreased by 5.78% to -$2.8 billion in 2022, then crashed by 376.89% to -$13.5 billion in 2023, then decreased by 12.11% to -$15.2 billion in 2024, then rose by 9.3% to -$13.8 billion in 2025.
  • Its last three reported values are -$13.8 billion in Q4 2025, -$14.2 billion for Q3 2025, and -$14.7 billion during Q2 2025.